Long-term outcomes after therapeutic endoscopic retrograde cholangiopancreatography using balloon-assisted enteroscopy for anastomotic stenosis of choledochojejunostomy/pancreaticojejunostomy

Itsuki Sano, Akio Katanuma, Masaki Kuwatani, Hiroshi Kawakami, Hironari Katou, Takao Itoi, Michihiro Ono, Atsushi Irisawa, Yoshinobu Okabe, Takuji Iwashita, Ichiro Yasuda, Shomei Ryozawa, Seiji Kaino, Naoya Sakamoto

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background and Aim: Data on long-term outcomes after therapeutic endoscopic retrograde cholangiopancreatography (ERCP) using balloon-assisted enteroscopy (BAE) for choledochojejunal anastomotic stenosis (CJS) or pancreaticojejunal anastomotic stenosis (PJS) remain limited. We retrospectively assessed the long-term results of patients who achieved clinical success using BAE for CJS and PJS. Methods: Patients who achieved technical and clinical success for CJS or PJS by BAE-ERCP and were followed up for more than 6 months after the initial BAE-ERCP therapy were retrospectively identified at 11 Japanese institutions. The primary end-point was CJS or PJS recurrence rates. The secondary end-points were initial therapy details, initial therapy complications, and CJS or PJS recurrence treatment details. We also evaluated restenosis-associated factors. Results: From September 2008 to December 2015, 67 patients (CJS, 61; PJS, six) were included. The overall CJS and PJS recurrence rates were 34.4% and 33.3%, respectively. The 1-year CJS recurrence rate was 18.5% (95% confidence interval, 10.7–31.0). Of all the patients, 88.1% underwent balloon dilation at the anastomotic stenosis site; stent placement was performed in 15 of 67 patients (22.4%). The complication rate was 8.2% in CJS and 0% in PJS. In patients who underwent balloon dilation, “remaining waist” was significantly associated with CJS recurrence after anastomotic balloon dilation (P = 0.001). Conclusions: The long-term outcomes of BAE-ERCP were comparable with those of percutaneous transhepatic treatment or surgical re-anastomosis.

Original languageEnglish
Pages (from-to)612-619
Number of pages8
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume34
Issue number3
DOIs
Publication statusPublished - Mar 1 2019

Fingerprint

Pancreaticojejunostomy
Choledochostomy
Endoscopic Retrograde Cholangiopancreatography
Pathologic Constriction
Therapeutics
Recurrence
Balloon Enteroscopy
Dilatation
Surgical Anastomosis

Keywords

  • anastomotic stenosis
  • balloon-assisted endoscopy
  • choledochojejunostomy
  • ERCP
  • pancreaticojejunostomy

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Long-term outcomes after therapeutic endoscopic retrograde cholangiopancreatography using balloon-assisted enteroscopy for anastomotic stenosis of choledochojejunostomy/pancreaticojejunostomy. / Sano, Itsuki; Katanuma, Akio; Kuwatani, Masaki; Kawakami, Hiroshi; Katou, Hironari; Itoi, Takao; Ono, Michihiro; Irisawa, Atsushi; Okabe, Yoshinobu; Iwashita, Takuji; Yasuda, Ichiro; Ryozawa, Shomei; Kaino, Seiji; Sakamoto, Naoya.

In: Journal of Gastroenterology and Hepatology (Australia), Vol. 34, No. 3, 01.03.2019, p. 612-619.

Research output: Contribution to journalArticle

Sano, Itsuki ; Katanuma, Akio ; Kuwatani, Masaki ; Kawakami, Hiroshi ; Katou, Hironari ; Itoi, Takao ; Ono, Michihiro ; Irisawa, Atsushi ; Okabe, Yoshinobu ; Iwashita, Takuji ; Yasuda, Ichiro ; Ryozawa, Shomei ; Kaino, Seiji ; Sakamoto, Naoya. / Long-term outcomes after therapeutic endoscopic retrograde cholangiopancreatography using balloon-assisted enteroscopy for anastomotic stenosis of choledochojejunostomy/pancreaticojejunostomy. In: Journal of Gastroenterology and Hepatology (Australia). 2019 ; Vol. 34, No. 3. pp. 612-619.
@article{a7f11c11e63e4127a6a1185242d9d51b,
title = "Long-term outcomes after therapeutic endoscopic retrograde cholangiopancreatography using balloon-assisted enteroscopy for anastomotic stenosis of choledochojejunostomy/pancreaticojejunostomy",
abstract = "Background and Aim: Data on long-term outcomes after therapeutic endoscopic retrograde cholangiopancreatography (ERCP) using balloon-assisted enteroscopy (BAE) for choledochojejunal anastomotic stenosis (CJS) or pancreaticojejunal anastomotic stenosis (PJS) remain limited. We retrospectively assessed the long-term results of patients who achieved clinical success using BAE for CJS and PJS. Methods: Patients who achieved technical and clinical success for CJS or PJS by BAE-ERCP and were followed up for more than 6 months after the initial BAE-ERCP therapy were retrospectively identified at 11 Japanese institutions. The primary end-point was CJS or PJS recurrence rates. The secondary end-points were initial therapy details, initial therapy complications, and CJS or PJS recurrence treatment details. We also evaluated restenosis-associated factors. Results: From September 2008 to December 2015, 67 patients (CJS, 61; PJS, six) were included. The overall CJS and PJS recurrence rates were 34.4{\%} and 33.3{\%}, respectively. The 1-year CJS recurrence rate was 18.5{\%} (95{\%} confidence interval, 10.7–31.0). Of all the patients, 88.1{\%} underwent balloon dilation at the anastomotic stenosis site; stent placement was performed in 15 of 67 patients (22.4{\%}). The complication rate was 8.2{\%} in CJS and 0{\%} in PJS. In patients who underwent balloon dilation, “remaining waist” was significantly associated with CJS recurrence after anastomotic balloon dilation (P = 0.001). Conclusions: The long-term outcomes of BAE-ERCP were comparable with those of percutaneous transhepatic treatment or surgical re-anastomosis.",
keywords = "anastomotic stenosis, balloon-assisted endoscopy, choledochojejunostomy, ERCP, pancreaticojejunostomy",
author = "Itsuki Sano and Akio Katanuma and Masaki Kuwatani and Hiroshi Kawakami and Hironari Katou and Takao Itoi and Michihiro Ono and Atsushi Irisawa and Yoshinobu Okabe and Takuji Iwashita and Ichiro Yasuda and Shomei Ryozawa and Seiji Kaino and Naoya Sakamoto",
year = "2019",
month = "3",
day = "1",
doi = "10.1111/jgh.14605",
language = "English",
volume = "34",
pages = "612--619",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Long-term outcomes after therapeutic endoscopic retrograde cholangiopancreatography using balloon-assisted enteroscopy for anastomotic stenosis of choledochojejunostomy/pancreaticojejunostomy

AU - Sano, Itsuki

AU - Katanuma, Akio

AU - Kuwatani, Masaki

AU - Kawakami, Hiroshi

AU - Katou, Hironari

AU - Itoi, Takao

AU - Ono, Michihiro

AU - Irisawa, Atsushi

AU - Okabe, Yoshinobu

AU - Iwashita, Takuji

AU - Yasuda, Ichiro

AU - Ryozawa, Shomei

AU - Kaino, Seiji

AU - Sakamoto, Naoya

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Background and Aim: Data on long-term outcomes after therapeutic endoscopic retrograde cholangiopancreatography (ERCP) using balloon-assisted enteroscopy (BAE) for choledochojejunal anastomotic stenosis (CJS) or pancreaticojejunal anastomotic stenosis (PJS) remain limited. We retrospectively assessed the long-term results of patients who achieved clinical success using BAE for CJS and PJS. Methods: Patients who achieved technical and clinical success for CJS or PJS by BAE-ERCP and were followed up for more than 6 months after the initial BAE-ERCP therapy were retrospectively identified at 11 Japanese institutions. The primary end-point was CJS or PJS recurrence rates. The secondary end-points were initial therapy details, initial therapy complications, and CJS or PJS recurrence treatment details. We also evaluated restenosis-associated factors. Results: From September 2008 to December 2015, 67 patients (CJS, 61; PJS, six) were included. The overall CJS and PJS recurrence rates were 34.4% and 33.3%, respectively. The 1-year CJS recurrence rate was 18.5% (95% confidence interval, 10.7–31.0). Of all the patients, 88.1% underwent balloon dilation at the anastomotic stenosis site; stent placement was performed in 15 of 67 patients (22.4%). The complication rate was 8.2% in CJS and 0% in PJS. In patients who underwent balloon dilation, “remaining waist” was significantly associated with CJS recurrence after anastomotic balloon dilation (P = 0.001). Conclusions: The long-term outcomes of BAE-ERCP were comparable with those of percutaneous transhepatic treatment or surgical re-anastomosis.

AB - Background and Aim: Data on long-term outcomes after therapeutic endoscopic retrograde cholangiopancreatography (ERCP) using balloon-assisted enteroscopy (BAE) for choledochojejunal anastomotic stenosis (CJS) or pancreaticojejunal anastomotic stenosis (PJS) remain limited. We retrospectively assessed the long-term results of patients who achieved clinical success using BAE for CJS and PJS. Methods: Patients who achieved technical and clinical success for CJS or PJS by BAE-ERCP and were followed up for more than 6 months after the initial BAE-ERCP therapy were retrospectively identified at 11 Japanese institutions. The primary end-point was CJS or PJS recurrence rates. The secondary end-points were initial therapy details, initial therapy complications, and CJS or PJS recurrence treatment details. We also evaluated restenosis-associated factors. Results: From September 2008 to December 2015, 67 patients (CJS, 61; PJS, six) were included. The overall CJS and PJS recurrence rates were 34.4% and 33.3%, respectively. The 1-year CJS recurrence rate was 18.5% (95% confidence interval, 10.7–31.0). Of all the patients, 88.1% underwent balloon dilation at the anastomotic stenosis site; stent placement was performed in 15 of 67 patients (22.4%). The complication rate was 8.2% in CJS and 0% in PJS. In patients who underwent balloon dilation, “remaining waist” was significantly associated with CJS recurrence after anastomotic balloon dilation (P = 0.001). Conclusions: The long-term outcomes of BAE-ERCP were comparable with those of percutaneous transhepatic treatment or surgical re-anastomosis.

KW - anastomotic stenosis

KW - balloon-assisted endoscopy

KW - choledochojejunostomy

KW - ERCP

KW - pancreaticojejunostomy

UR - http://www.scopus.com/inward/record.url?scp=85062239590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062239590&partnerID=8YFLogxK

U2 - 10.1111/jgh.14605

DO - 10.1111/jgh.14605

M3 - Article

C2 - 30650206

AN - SCOPUS:85062239590

VL - 34

SP - 612

EP - 619

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - 3

ER -